Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
News Release Digital Asset Direct

NAVEX Announces 2024 Excellence Awards Finalists

NAVEX Global

NAVEX, a leading provider of integrated risk and compliance management software, announces today the 2024 NAVEX Excellence Awards finalists. Now in its fourth year, the awards celebrate organizations that demonstrate exceptional commitment to corporate governance, risk mitigation, and ethical practices. Each year, the NAVEX Excellence Awards highlight how robust governance, risk and compliance (GRC) programs can strengthen corporate culture and meaningfully impact business outcomes that matter. The 2024 finalists exemplify how effective GRC initiatives can proactively manage and mitigate risks when woven into the organizational fabric. "Congratulations to this year’s nominees and finalists for their outstanding achievements," said NAVEX Chief Customer Officer, Steve Chapman. "We are proud to partner with customers who are dedicated to advancing their GRC efforts. These awards shine a spotlight on some of the most innovative and effective programs in the industry, and we applaud the compliance teams at these companies for their ongoing efforts to build highly ethical, risk-aware organizations." The winners will be honored in several categories, including Ethics & Compliance, Risk Management, and Risk and Compliance Program of the Year. Selected from a highly competitive pool of nominations, this year’s finalists include: As in previous years, the judging panel brings together a mix of NAVEX leaders and seasoned GRC professionals. This year’s esteemed panel features: Barbara Boehler, Senior Director, Program on Corporate Compliance and Ethics, Fordham Law Bill Cameron, Founder and Principal, Cameron Advisory Services Carol Williams, CEO and Enterprise Risk Management Consultant, Strategic Decision Solutions Carrie Penman, Chief Risk and Compliance Officer, NAVEX Kyle Brasseur, Former Editor in Chief, Compliance Week Kyle Martin, Vice President of GRC Solutions, NAVEX Matt Kelly, Editor and CEO, Radical Compliance LLC Stephen Chapman, Chief Customer Officer, NAVEX Vera Cherepanova, Ethics Advocate, Consultant, Author, Studio Etica Award recipients will be announced after to the 2024 NAVEX Next Virtual Conference on October 1. NAVEX is trusted by thousands of customers worldwide to help them achieve the business outcomes that matter most. As the global leader in integrated risk and compliance management software and services, we deliver solutions through the NAVEX One platform, the industry’s most comprehensive governance, risk and compliance (GRC) information system. For more information, visit NAVEX.com and our blog. Follow us on Twitter and LinkedIn. Contact Details Navex Global +1 617-388-5773 scott.levesque@navex.com Company Website https://navex.com

September 03, 2024 08:06 AM Eastern Daylight Time

News Release

Strong Management and Partners Make Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) a Compelling Opportunity

Railtown AI

Artificial intelligence has rapidly evolved from a futuristic concept to a central component of modern business strategy. With the AI market projected to surge from $196.63 billion in 2023 to transformative levels by 2030, businesses across all sectors are leveraging AI to boost efficiency, cut costs, and secure a competitive advantage. From automating complex tasks to enhancing customer interactions, AI is revolutionizing industries. As the AI sector expands, investors are increasingly turning their attention to companies driving this innovation. One standout example is Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF), a company poised to make significant waves in the industry. Railtown AI Technologies Inc. is emerging as a standout player in the artificial intelligence landscape, driven by its robust management team and strategic partnerships. The company's focus on AI solutions, particularly through its innovative Conductor AI platform, underscores its potential to transform various sectors. Core Technology and Offerings Railtown's cloud-based Application General Intelligence Platform stands out for its flexibility, supporting both cloud and on-premise deployments. It uses machine learning to adapt from connected applications, which enhances decision-making and reduces operational costs. The platform’s real-time processing capabilities are crucial for efficient software development. Key Features Root Cause Analyzer: Identifies and prioritizes errors, saving developers over eight hours a week and reducing maintenance costs. Conductor AI Assistant: Provides instant, natural language responses to development queries and continuously improves based on user feedback. Velocity Dashboard: Tracks performance metrics, aiding management in planning and resource allocation. Release Notes Automator: Generates clear release notes in under two minutes, ensuring consistency and saving time. Ticket Generator: Uses AI to streamline ticket creation, minimizing manual input and allowing more focus on coding. API No-Code Virtual Developer: Enables users to create new functionalities without coding skills, democratizing development and boosting productivity. Strategic Partnerships Railtown AI Technologies Inc.’s partnerships play a crucial role in amplifying its technological capabilities and market reach. In July 2024, RALIF secured a strategic alliance with Mila, the Quebec Artificial Intelligence Institute, under the leadership of Professor Yoshua Bengio. This partnership provides Railtown with access to Mila’s cutting-edge research and a network of AI experts. It allows Railtown to integrate the latest advancements in deep learning into its Conductor AI platform, further enhancing its technological prowess. Mila’s involvement also aids in talent acquisition and training, ensuring that Railtown remains at the forefront of AI innovation. Similarly, Railtown AI's collaboration with the Alberta Machine Intelligence Institute (Amii), announced in July 2024, is instrumental in advancing its capabilities. Amii’s expertise in reinforcement learning and natural language processing complements Railtown’s technology, contributing to the refinement of its AI solutions. This partnership brings additional expertise and resources to Railtown, accelerating the development of sophisticated AI applications. Furthermore, Railtown retains ownership of all intellectual property developed through this collaboration, which strengthens its competitive position in the market. The company's earlier partnership with Quisitive Technology Solutions Inc. highlights its commitment to practical applications of AI. This integration incorporates Railtown’s AI technology into Quisitive’s Velocity Insights toolset, enhancing software engineering productivity and project management. This partnership showcases Railtown’s ability to apply its technology effectively in real-world scenarios, expanding its influence within enterprise environments. Leadership Driving Innovation Railtown AI’s leadership team is a key asset, guiding the company through its growth and innovation journey. Cory Brandolini, Founder and CEO, brings over 30 years of experience in technology and software ventures. His background includes raising significant capital for technology companies and leading successful exits, such as the acquisition of Teleo Inc. by Microsoft. Brandolini’s strategic vision and industry connections are vital for steering Railtown AI towards its ambitious goals. Co-Founder and CTO Marwan Haddad contributes over 25 years of experience in software development, having led engineering teams at major tech platforms like RESAAS and Fortune 500 companies. Haddad’s technical expertise ensures that Railtown’s AI solutions are developed and executed to the highest standards. Dr. Elliot Holtham, Co-Founder and AI Data Scientist, brings extensive experience in machine learning and data science. His previous role at Xtract AI, acquired by Patriot One Technologies, and his academic achievements bolster Railtown’s R&D efforts and drive innovation within its technology offerings. Kevin O’Neil, Advisory Chair, offers a wealth of experience in technology investing and advisory roles. His previous role as CEO of Xtract AI and his expertise in strategic guidance and investment reinforce Railtown’s market strategy and growth trajectory. Conclusion Railtown AI Technologies Inc. represents an intriguing investment opportunity, distinguished by its innovative Conductor AI platform, strategic partnerships, and a seasoned leadership team. The collaborations with Mila and Amii enhance Railtown’s technological capabilities and research potential, while the partnership with Quisitive illustrates the practical application of its AI solutions. With a management team renowned for its expertise and a clear focus on delivering advanced AI technologies, Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) could be a stock to watch for continued success in the evolving artificial intelligence sector. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website http://razorpitch.com

September 03, 2024 06:00 AM Eastern Daylight Time

Aligning Investment Strategies through the Health Care Select Sector SPDR Fund (XLV)

Select Sector SPDR

In the evolving landscape of healthcare, the Health Care Select Sector SPDR Fund (XLV) stands as an investment vehicle for those looking to diversify their portfolio within the U.S. healthcare sector. By tracking healthcare stocks within the S&P 500 Index, XLV offers broad exposure to foundational companies that are central to healthcare in America. Featuring a blend of leading entities across various sub-sectors, XLV's holdings provide investors with exposure to many of the healthcare sector’s diverse industries. Highlighting XLV's Key Holdings* The fund's composition showcases a selection of companies pivotal to healthcare’s wide-ranging facets: Eli Lilly (LLY) - 11.66% UnitedHealth (UNH) - 9.63% Johnson & Johnson (JNJ) - 6.90% AbbVie (ABBV) - 5.94% Merck (MRK) - 5.20% Thermo Fisher Scientific (TMO) - 4.25% Abbott Labs (ABT) - 3.35% Danaher (DHR) - 3.32% Amgen (AMGN) - 3.24% Pfizer (PFE) - 3.14% These holdings span pharmaceuticals, health insurance, medical devices, and diagnostics, illustrating the fund's encompassing approach to the healthcare sector. Sector Dynamics Influencing Healthcare Engagement The healthcare sector is characterized by factors such as demographic trends, technological advancements, and shifts in healthcare delivery models. These elements contribute to the sector's role within the broader economy and its relevance to consumer needs. Healthcare spending's share of Gross Domestic Product (GDP) has maintained a significant position, reflecting the sector's integral role in the economic landscape. This dynamic underscores the steady relevance of healthcare in consumer and governmental expenditure. The Strategic Appeal of the XLV Fund Investing in the Health Care Select Sector SPDR Fund (XLV) allows individuals to engage with the healthcare sector through a vehicle that offers balanced and diversified exposure. The fund's structure is designed to mitigate the risks associated with investing in individual companies by providing a portfolio that reflects the sector's breadth. For investors seeking a methodical approach to incorporating healthcare into their investment portfolios, XLV presents a tactful option. The fund's focus on core healthcare companies, coupled with its diversified strategy, affords a stable pathway to participation in the sector's activities. DISCLAIMER: This is a work of research and should not be taken as investment or financial advice. Therefore, Select Sector SPDRs or the publisher is not liable for any decision made based on the publication. About the Company: Select Sector SPDR ETFs offer flexibility and customization opportunities. Many investors have similar outlooks, but no two are exactly alike. Select Sector SPDR ETFs let investors select the sectors that best meet their investment goals. *Holdings, Weightings & Assets as of 7/31/24 subject to change DISCLOSURES The S&P 500 Index is an unmanaged index of 500 common stocks that is generally considered representative of the U.S. stock market. The index is heavily weighted toward stocks with large market capitalizations and represents approximately two-thirds of the total market value of all domestic common stocks. The S&P 500 Index figures do not reflect any fees, expenses or taxes. An investor should consider investment objectives, risks, fees and expenses before investing. One may not invest directly in an index. Transparent ETFs provide daily disclosure of portfolio holdings and weightings All ETFs are subject to risk, including loss of principal. Sector ETF products are also subject to sector risk and nondiversification risk, which generally will result in greater price fluctuations than the overall market. Diversification does not eliminate risk. An investor should consider investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, which contains this and other information, call 1-866-SECTOR-ETF (732-8673) or visit www.sectorspdrs.com. Read the prospectus carefully before investing. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is distributor for the Select Sector SPDR Trust. Media Contact: Company: Select Sector SPDRs Contact: Dan Dolan* Address: 1290 Broadway, Suite 1000, Denver, CO 80203 Country: United States Email: dan.dolan@sectorspdrs.com Website: https://www.sectorspdrs.com/ *Dan Dolan is a Registered Representative of ALPS Portfolio Solutions Distributor, Inc. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is the distributor for the Select Sector SPDR Trust. SEL007756 EXP 10/31/24 Contact Details Dan Dolan +1 203-935-8103 dan.dolan@sectorspdrs.com Company Website https://www.sectorspdrs.com/

September 02, 2024 05:00 AM Eastern Daylight Time

Justin Sun Presents Keynote Speech at WebX 2024, TRON DAO Featured as Title Sponsor

TRON DAO

Geneva, Switzerland, August 30, 2024 - WebX 2024, a global Web3 conference organized by CoinPost, welcomed TRON DAO as a Title Sponsor and welcomed its visionary founder, Justin Sun, as a keynote speaker. Additionally, TRON DAO played a key role as a Platinum Sponsor at OKJ Night and a sponsor at the WebX Official Afterparty. WebX 2024 is a premier global Web3 conference organized and managed by CoinPost, Japan's largest Web3 media. As one of Asia's largest gathering of professionals in the crypto, blockchain, and Web3 spaces, WebX 2024 brought together companies, experts, entrepreneurs, investors, government officials, and media from Japan and abroad, creating a unique space for direct interaction and collaboration. TRON DAO played an integral role at WebX 2024, engaging in multiple sessions and making substantial contributions to the dynamic discussions and networking opportunities that the event provided. Justin Sun’s Keynote In his keynote, Sun emphasized the critical role of building dynamic and diverse ecosystems that genuinely empower communities. He articulated how the TRON blockchain ecosystem is an environment where everyone can discover their place and contribute meaningfully. Sun's commitment to building solutions that empower individuals and bring communities together has been one of the contributing forces behind TRON's rapid growth, highlighting how a people-first philosophy can lead to significant advancements in the blockchain space. WebX Official Afterparty The official afterparty, sponsored by TRON DAO, took place at Zouk Tokyo, where speakers, VIP guests, and participants gathered to celebrate the final day of WebX. The event provided a vibrant setting for attendees to unwind, network, and reflect on the conference's success while enjoying music, drinks, and the dynamic atmosphere that encapsulated the spirit of innovation and collaboration fostered throughout the event. OKJ Night As an official side event of WebX, OKJ Night stood out as a memorable celebration, marking the significant rebranding of OKCoinJapan to OKJ. Supported by TRON DAO as a Platinum Sponsor, the event gathered industry leaders, setting the stage for future growth and collaboration in the blockchain space. WebX 2024 was a remarkable convergence of innovation and collaboration, with TRON DAO at the forefront as a Title Sponsor. The conference underscored the power of building diverse and dynamic ecosystems, a vision articulated by Justin Sun in his keynote speech. His focus on community empowerment and the inclusive nature of the TRON ecosystem resonated deeply, highlighting how blockchain can drive meaningful change. With TRON DAO’s involvement as a Platinum Sponsor at the OKJ Night and sponsor at the WebX Official Afterparty, the event truly embodied the spirit of unity and progress. As the blockchain industry continues to evolve, TRON DAO remains committed to fostering environments where innovation can thrive and communities can flourish. About TRON DAO TRON DAO is a community-governed DAO dedicated to accelerating the decentralization of the internet via blockchain technology and dApps. Founded in September 2017 by H.E. Justin Sun, the TRON network has continued to deliver impressive achievements since MainNet launch in May 2018. July 2018 also marked the ecosystem integration of BitTorrent, a pioneer in decentralized Web3 services boasting over 100 million monthly active users. The TRON network has gained incredible traction in recent years. As of August 2024, it has over 252 million total user accounts on the blockchain, more than 8 billion total transactions, and over $22 billion in total value locked (TVL), as reported on TRONSCAN. In addition, TRON hosts the largest circulating supply of USD Tether (USDT) stablecoin across the globe, overtaking USDT on Ethereum since April 2021. The TRON network completed full decentralization in December 2021 and is now a community-governed DAO. Most recently in October 2022, TRON was designated as the national blockchain for the Commonwealth of Dominica, which marks the first time a major public blockchain partnered with a sovereign nation to develop its national blockchain infrastructure. On top of the government’s endorsement to issue Dominica Coin (“DMC”), a blockchain-based fan token to help promote Dominica’s global fanfare, seven existing TRON-based tokens - TRX, BTT, NFT, JST, USDD, USDT, TUSD, have been granted statutory status as authorized digital currency and medium of exchange in the country. TRONNetwork | TRONDAO | Twitter | YouTube | Telegram | Discord | Reddit | GitHub | Medium | Forum Media Contact Yeweon Park press@tron.network Contact Details Yeweon Park press@tron.network Company Website https://trondao.org/

August 30, 2024 11:57 AM Eastern Daylight Time

Image

AAMC Revolutionises Motor Vehicle Accident Management with Advanced Claims Solutions

Rev Up Marketers

AAMC, a premier provider of motor vehicle accident management services, is setting a new standard in the industry with its innovative approach to Repair Management and in particular, Intermediated Motor Claims. Established in 2002, AAMC has grown to become a nationwide leader, known for its comprehensive solutions that cater to the unique needs of insurers, brokers, and their clients across Australia. AAMC's founders, Steve Chapman and Simon Manolaros, identified gaps in the motor loss assessing market over two decades ago. The motor assessing industry was fragmented, with small, localised providers dominating the landscape. AAMC was born out of a desire to offer a more structured, consistent service, and today, they stand as a testament to operational excellence. Their experienced team of motor loss assessors and customer service representatives are committed to delivering top-tier outcomes for their clients, who represent the majority of the Australian motor insurance sector. AAMC's latest innovation, the Intermediated Motor Team (IMT), represents a transformative approach to motor claims management. This unique framework is the first of its kind in Australia, designed to initiate expert intervention from the moment a motor incident occurs. By setting up the claim for success from Day Zero, IMT ensures a streamlined, efficient process that benefits all stakeholders—brokers, insurers, commercial customers, and supply chain managers alike. The IMT framework takes charge of all accident management activities immediately after an incident. From triaging damage to facilitating communications, assisting with repair estimates, and beginning the assessment process, IMT provides a seamless claims experience. The focus on early intervention and proactive management means that claims progress quickly through the triage, booking, assessment and repair stages, reducing delays and ensuring that all parties are kept informed and satisfied. The time between the initial incident and the lodgement of a claim is crucial. Policyholders can sometimes be left to navigate repairs and manage business interruptions on their own, with insurers unable to implement cost-saving strategies until much later in the claim cycle. AAMC's IMT changes this dynamic by offering immediate support and guidance, allowing for meaningful cost control and a well-supported claims experience. For brokers, the IMT model represents a significant enhancement to their insurance offerings. It enables them to provide a high-quality, best-practice claims capability, ensuring that their clients receive the support they need during a critical time. This early intervention approach mitigates costs, identifies damage early, and engages with repairers and third parties proactively, resulting in a smoother, more efficient claims process and reduces the need for brokers or their clients to chase up insurers for updates, saving valuable time and resources. The transparency provided by IMT ensures that all parties involved in a claim have clear visibility of its status and what to expect next. By offering early expert intervention, IMT delivers a seamless, efficient claims process that benefits brokers, insurers, and clients alike, leading to higher satisfaction among all stakeholders. AAMC's commitment to operational excellence and customer satisfaction continues to set them apart as leaders in the field. To learn more about their services, visit their website. About AAMC AAMC is the largest and most experienced provider of specialist accident management and assessing services to the Australian motor insurance and associated industries. Since its inception in 2002, AAMC have been building and developing expertise, systems, and capabilities to facilitate every aspect of a motor vehicle accident. This includes their contact centre for customer interaction, dedicated suppliers to reinstate vehicle damage, and their in-house assessors and technical experts who mitigate costs. With a core focus on optimising the performance and efficiency of intermediated motor teams, AAMC offers a unique Intermediated Motor Team (IMT) framework that redefines the way motor insurance claims are handled. Contact Details AAMC Jennifer Hodges brisbane@aamc.com.au Company Website https://www.aamc.com.au/

August 30, 2024 08:03 AM Eastern Daylight Time

Image

Synergist Technology Partners with Microsoft to Drive Ethical and Compliant AI Innovation

Synergist

Synergist Technology, a leader in AI governance and compliance, announces a strategic partnership with Microsoft, aimed at advancing the development and deployment of compliant AI solutions. By integrating Synergist’s expertise with Microsoft’s robust cloud infrastructure, the partnership seeks to address the growing market demands for ethical and secure AI systems. As the rapid adoption of AI continues to outpace regulatory frameworks, many organizations face significant challenges in deploying AI technologies with accountability. Together, the companies will provide comprehensive AI solutions that help businesses navigate the complex landscape of AI regulations while maximizing the potential of Microsoft’s AI offerings. The partnership is further strengthened by the involvement of key partners, including Pliant Consulting and Maureen Data Systems, which will assist in integrating and enhancing AI solutions for clients. This collaborative effort ensures that customers can navigate the complexities of AI governance with ease and assurance. “With over 700 pieces of proposed regulation at the state and federal level, our partnership with Microsoft represents a significant step forward in our mission to bring responsible AI to every organization,” said Elycia Morris, CEO of Synergist Technology. “By combining our governance and compliance expertise with Microsoft’s advanced technologies, we are creating a powerful synergy that will enable organizations to harness the transformative power of AI while maintaining trust and transparency.” “This partnership enables organizations to confidently leverage AI’s transformative power while adhering to the highest standards of regulatory adherence,” said Vishal Amin, General Manager of Security Solutions, Microsoft. “Microsoft and Synergist have a shared commitment to empower businesses to achieve more through innovation and trust.” Since the inception of the partnership, Synergist has made significant strides in its go-to-market strategy, leveraging Microsoft programs such as the ISV Success Program to expand the reach of its offerings. This strategic collaboration is set to evolve further, with plans to integrate Synergist’s AFFIRM platform into Microsoft’s Marketplace, making it more accessible to businesses worldwide. About Synergist Technology Synergist Technologies is a leader in AI governance and compliance, specializing in enabling ethical and compliant AI innovation through their AFFIRM platform. Their solutions help organizations navigate the complexities of AI regulations, ensuring responsible and effective AI deployment.For more information, visit https://synergist.technology/. Contact Details Julia Worthington synergist@kitehillpr.com

August 29, 2024 09:00 AM Eastern Daylight Time

Benchmark International Releases Global Semiconductor Machinery Manufacturing Industry Report, Spotlighting Market Growth and Key Trends

Benchmark International

Benchmark International, a leader in the mergers and acquisition (M&A) industry, has published its latest Global Semiconductor Machinery Manufacturing Industry Report. This comprehensive analysis provides critical insights into the rapidly evolving semiconductor machinery sector, highlighting growth opportunities, industry challenges, and emerging trends that are reshaping the landscape. As the global demand for semiconductors continues to soar, driven by advancements in artificial intelligence, 5G, and consumer electronics, the semiconductor machinery manufacturing industry is experiencing significant growth. Benchmark International’s report delves into the key factors influencing this sector, from technological innovations to geopolitical developments that are shaping supply chains and market dynamics. Key highlights of the report include: Technological Advancements: The latest advancements in semiconductor machinery, highlighting innovations that are boosting production efficiency and driving next-generation semiconductor development. Market Drivers: An analysis of the rise of AI, IoT, and 5G technologies as key market drivers, significantly increasing the demand for advanced semiconductor machinery. Regional Market Dynamics: Insights into regional dynamics, focusing on the contributions and dominance of key players in North America, Asia-Pacific, and Europe. With semiconductor machinery manufacturing at the forefront of technological innovation, the report serves as an essential resource for industry professionals, investors, and companies looking to stay ahead in a highly competitive market. The report is now available on Benchmark International's website and is part of the firm’s ongoing efforts to provide comprehensive market intelligence to its clients. For more information and to access the full 2024 Global Semiconductor Machinery Manufacturing Industry Report, please visit https://www.benchmarkintl.com/insights/global-semiconductor-machinery-manufacturing-industry-report/ ABOUT BENCHMARK INTERNATIONAL: Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive Privately-held M&A Advisor in the World by Pitchbook and Refinitiv's Global League Tables. Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

August 29, 2024 09:00 AM Eastern Daylight Time

Image

Nuvectis Pharma Rises in Pre-Market Following FDA Orphan Drug Designation for NXP800, Fueling Optimism Ahead of Key Clinical Data

Global Markets News

Nuvectis Pharma (NASDAQ: NVCT) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Orphan Drug Designation for its lead candidate, NXP800. This designation, specifically for the treatment of ARID1a-deficient ovarian, fallopian tube, and primary peritoneal cancers, marks a critical step forward in Nuvectis’s mission to address unmet needs in oncology. Orphan Drug Designation: A Strategic Advantage The FDA’s Orphan Drug Designation is awarded to drugs that show promise in treating rare diseases affecting fewer than 200,000 people in the U.S. For Nuvectis, this designation not only validates the potential of NXP800 but also provides several strategic benefits. These include tax credits for clinical trial costs, exemption from certain FDA fees, and potentially seven years of market exclusivity upon approval. NXP800 targets ARID1a-deficient cancers, a subset of ovarian cancers that present significant treatment challenges. The Orphan Drug Designation underscores the importance of this candidate in potentially offering a new, more effective treatment option for patients with this specific genetic mutation. Background and Market Impact This latest achievement builds on Nuvectis Pharma’s earlier successes. Earlier this year, the FDA granted Fast Track Designation to NXP800 for its development in platinum-resistant, ARID1a-mutated ovarian cancer. The Fast Track status, combined with the Orphan Drug Designation, highlights the urgent need for innovative treatments in this space and positions NXP800 as a potential game-changer in oncology. Financial analysts have taken note of Nuvectis’s progress. H.C. Wainwright recently reiterated its buy rating for Nuvectis, setting a price target of $21. This optimistic outlook reflects the market’s confidence in the company’s strategic direction, particularly as it prepares to release key clinical data later this year. Anticipation for Upcoming Results The next few months are expected to be pivotal for Nuvectis Pharma. The company is poised to share updates from its ongoing Phase 1b clinical trial of NXP800, which targets patients with platinum-resistant, ARID1a-mutated ovarian cancer. This trial is being closely watched, as positive results could significantly advance the development of NXP800, bringing it closer to pivotal trials and eventual regulatory approval. Additionally, Nuvectis is also conducting a Phase 1a dose escalation study for NXP900, its second key candidate, which targets YES1/SRC-driven tumors. Updates from this study are expected to provide further insights into the safety and potential efficacy of NXP900. ### Nuvvectis' Full announcment, titled " Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers" was published on August 29th, 2024. ### This article is for informational purposes only and is not intended to serve as financial, investment or any form of professional advice, recommendation or endorsement. Please review the full documentation detailing financial compensation disclosures and disclaimers the article is subject to. https://justpaste.it/fcm9n/pdf. Global Markets News Network is a commercial digital brand compensated to provide coverage of innovative companies and industries and it is thus subject to conflicts of interest. Contact Details Global Markets News News Coverage ronald@futuremarketsresearch.com

August 29, 2024 08:20 AM Eastern Daylight Time

News Release

Railtown AI Technologies (CSE: RAIL) (OTCQB: RLAIF): Leveraging AI to Revolutionize Software Development Efficiency

Railtown AI

The global artificial intelligence (AI) market was estimated at $196.63 billion in 2023 and is expected to grow at a staggering compound annual growth rate (CAGR) of 36.6% from 2024 to 2030, according to Grand View Research. Once seen as the stuff of science fiction, AI has steadily integrated into our daily lives, evolving from a buzzword to a household presence. More importantly, AI is now a cornerstone of modern business, driving efficiencies, cutting costs, and enabling companies to compete in an increasingly digital world. Businesses are harnessing AI in various ways: enhancing cybersecurity, managing fraud, crafting content, and improving customer relationships. A Forbes survey reveals that over half of business owners use AI for cybersecurity, nearly half use it for internal communications, and 64% believe it will strengthen customer relationships. Additionally, 97% of business owners see AI tools like ChatGPT as beneficial to their operations, with many planning to use AI for website content and multilingual communication. Investing in AI stocks has surged as companies across sectors leverage advanced AI technologies to boost productivity and enhance decision-making. This shift is expected to drive revenue and earnings growth in the coming years. With that in mind, it could be the right time to start looking into AI stocks. Now, let’s look at a rising company in this competitive sector. Railtown AI Technologies (CSE: RAIL) (OTCQB: RLAIF) is emerging as a promising player in the AI sector, offering innovative solutions that streamline software development. As a Microsoft Partner, Railtown AI has developed a cloud-based Application General Intelligence (AGI) platform designed to support software developers and Agile teams. The company’s primary focus is to save time on repetitive tasks, improve productivity, reduce costs, and accelerate developer velocity. This platform is readily accessible via Microsoft's Azure Marketplace, making it easily available to a broad range of businesses. What Railtown AI Technologies Does Railtown AI ’s proprietary platform is entirely owned and developed in-house, ensuring that the company has complete control over its technology. The platform is particularly notable for its dual deployment options, catering to organizations with different needs by offering both cloud-based and on-premise solutions. This flexibility, combined with the platform’s ability to process data quickly and learn over time, allows businesses to make real-time decisions and continuously improve their software development processes. The platform’s AI-driven tools target key areas in software development, offering significant benefits. The Root Cause Analyzer detects and alerts developers to errors early, allowing them to resolve issues before they affect users, thereby saving valuable time and reducing costs. The Conductor AI Assistant provides developers with quick, accurate information to solve problems faster, continuously learning from developer feedback to improve its capabilities. The Velocity Dashboard tracks the performance of development teams, helping management make informed decisions on resource allocation and performance management. Additionally, tools like the Release Notes Automator and Ticket Generator automate traditionally manual tasks, further boosting productivity and enabling teams to focus on more strategic work. Why It Matters In a world where software development is increasingly complex and fast-paced, the ability to streamline processes and reduce manual work is critical. Railtown AI’s platform addresses this need by offering tools that not only enhance developer productivity but also ensure higher-quality software. This is particularly important as the industry moves towards Agile practices, which prioritize quick iterations and continuous improvement. By enabling faster and more accurate development cycles, Railtown AI helps organizations stay competitive in a rapidly evolving market. Moreover, Railtown AI's focus on compliance with industry standards such as SOC 2, GDPR, and ISO 27001 is a significant advantage. These compliance achievements build customer trust by ensuring that the platform handles data responsibly and securely. In industries like finance and healthcare, where data protection is paramount, this compliance is not just a nice-to-have but a necessity. As Railtown AI continues to meet these standards, it positions itself as a trustworthy partner for businesses looking to integrate AI into their software processes. The Potential of Railtown AI Technologies Railtown AI has achieved several milestones that indicate its potential for growth. The company recently announced its debt-free status, strengthened its capital base through private placements, and made significant progress in meeting compliance requirements. These achievements, combined with strategic partnerships with leading institutions like the Mila Quebec AI Institute and Amii Alberta Machine Learning Institute, set the stage for future growth. These partnerships are particularly noteworthy as they provide Railtown AI with access to cutting-edge research and development support. For instance, Mila covers 90% of project costs for its research phase with Railtown, while Amii covers 50% of project costs. This financial support, coupled with expertise from PhD candidates and machine learning engineers, enhances Railtown AI ’s ability to innovate and improve its platform. Looking ahead, Railtown AI is poised to capitalize on its compliance achievements by investing in customer acquisition, marketing, and direct sales. The company’s plans to update its patents and explore certification as a vendor for major brands further bolster its growth prospects. As Railtown AI Technologies continues to enhance its platform and expand its market presence, its strategic innovations and strong growth potential make it a compelling stock to watch in the rapidly evolving AI sector. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website https://razorpitch.com

August 29, 2024 06:00 AM Eastern Daylight Time

1 ... 29 30 31 32 33 ... 633